Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00381433 | Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid | PHASE1 | COMPLETED | 12 | — | — | Sep 1, 2006 | Jun 1, 2009 | Jul 8, 2009 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| AVI-4065 Injection | DRUG | - |
Inclusion Criteria: * Adult males 18 years to 64 years of age; * Good general health (as evidenced by no chronic conditions, normal physical exam, vital signs within normal limits; laboratory evaluations within normal range) * Signed and dated written informed consent form; and * Willing to partici...